Search results
An early onset and the rate of decline in lung function further increase CVD risk. Associations of pulmonary function with coronary artery disease are more modest and largely attenuate after accounting for other common risk factors.
20 maj 2021 · Although the current study highlights the potential benefits of personalizing dose according to exacerbation phenotype, two important limitations are the composite primary end point of treatment failure and the open-label design.
3 maj 2014 · Patients receiving prednisone had significant improvement in lung function at day 10 when compared to placebo (mean FEV 1 increase of 34% in prednisone-treated group versus 15% in placebo group, P=0.007). There was no significant difference in hospitalization rates between the two groups (21% of patients in the placebo group required ...
Steroids help control metabolism, inflammation, immune function, salt and water balance, development of sexual characteristics and your ability to withstand the stress of illness and injury. One of the steroids produced by the outer portion of the adrenal glands is called cortisone.
15 gru 2017 · In a recent editorial by one thought leader, it was stated: “The minimum effective corticosteroid dose is precisely defined, and differs from patient to patient and for different organs. For chronic pulmonary sarcoidosis, the range is typically between 5 and 15 mg per day (most often 10–15 mg)” [10].
20 lut 2023 · We read with great interest a recent report which shows virus-negative inflammatory cardiomyopathy benefits from immunosuppressive therapy even after long-term follow-up. 1 We noted prednisone, as the component of combination therapy may play a crucially cardioprotective role.
26 lip 2023 · The review reports that oral steroids may improve lung function, reduce shortness of breath, and result in lower relapse rates for people with moderate and severe COPD exacerbations.
